The world-wide market share of biologic drugs is advancing at a staggering pace, with some estimates ranging from $ 300 billion to $452 billion in revenue within the next five years.The treatment costs for patients...more
11/11/2020
/ Biologics ,
Biosimilars ,
Biotechnology ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Generic Drugs ,
Life Sciences ,
Orange Book ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs ,
Purple Book